Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dingzhou D. Li"'
Publikováno v:
Journal of Medical Primatology. 52:64-78
The cynomolgus macaque has become the most used non-human primate species in nonclinical safety assessment during the past decades.This review summarizes the biological data and organ system development milestones of the cynomolgus macaque available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205702db5132060e4a73a9518be47081
https://doi.org/10.1111/jmp.12622
https://doi.org/10.1111/jmp.12622
Autor:
Li D; Pfizer Inc., Global Biometrics and Data Management, 445 Eastern Point Road, Groton, Connecticut, 06340, USA. Electronic address: dingzhou.li@pfizer.com., Garren J; Pfizer Inc., Global Biometrics and Data Management, 445 Eastern Point Road, Groton, Connecticut, 06340, USA., Mangipudy R; Pfizer Inc., Drug Safety Research and Development, 445 Eastern Point Road, Groton, Connecticut, 06340, USA., Martin M; Pfizer Inc., Drug Safety Research and Development, 445 Eastern Point Road, Groton, Connecticut, 06340, USA., Tomlinson L; Pfizer Inc., Drug Safety Research and Development, 445 Eastern Point Road, Groton, Connecticut, 06340, USA., Vansell NR; Pfizer Inc., Drug Safety Research and Development, 445 Eastern Point Road, Groton, Connecticut, 06340, USA.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2024 Oct 30, pp. 105733. Date of Electronic Publication: 2024 Oct 30.
Autor:
Boulay E; Charles River Laboratories, Laval, Quebec, Canada; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada., Authier S; Charles River Laboratories, Laval, Quebec, Canada; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada. Electronic address: simonauthier@hotmail.com., Bartko T; Labcorp Early Development Laboratories Inc, Madison, WI, USA., Greiter-Wilke A; Roche Pharma Research and Early Development, Basel, Switzerland., Leishman D; Eli Lilly and Company, Indianapolis, IN, USA., Li D; Pfizer, Inc, Groton, CT, USA., Nichols JV; Labcorp Early Development Laboratories Inc, Madison, WI, USA., Pierson J; Health and Environmental Sciences Institute (HESI), Washington, DC, USA., Rossman EI; GSK, King of Prussia, PA, USA., Valentin JP; UCB Biopharma SPRL, Brussels, Belgium., Vicente J; Center for Drug Evaluation and Research, US Food & Drug Administration (FDA), Silver Spring, MD, USA., Walisser J; Labcorp Early Development Laboratories Inc, Madison, WI, USA., Troncy E; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada., Wisialowski TA; Pfizer, Inc, Groton, CT, USA.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 Sep-Oct; Vol. 129, pp. 107543. Date of Electronic Publication: 2024 Jul 15.
Autor:
Potter D; Nonclinical Statistics, R&D, Pfizer Inc, Cambridge, Massachusetts, USA., Bradstreet T; Independent Statistical Mentor for Preclinical Scientists, Landsdale, Pennsylvania, USA., Sargsyan D; Translational Medicine and Early Development Statistics, Johnson & Johnson, New Brunswick, New Jersey, USA., Tan X; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Bonato V; Nonclinical Statistics, R&D, Pfizer Inc, La Jolla, California, USA., Li D; Nonclinical Statistics, R&D, Pfizer Inc, Groton, Connecticut, USA., Liang J; Nonclinical Statistics, R&D, Pfizer Inc, Pearl River, New York, USA., Libiger O; Translational Medicine and Early Development Statistics, Johnson & Johnson, New Brunswick, New Jersey, USA., Sendecki J; Translational Medicine and Early Development Statistics, Johnson & Johnson, New Brunswick, New Jersey, USA., Stansfield J; Nonclinical Statistics, R&D, Pfizer Inc, Cambridge, Massachusetts, USA., Tatikola K; Translational Medicine and Early Development Statistics, Johnson & Johnson, New Brunswick, New Jersey, USA., Xu J; Translational Medicine and Early Development Statistics, Johnson & Johnson, New Brunswick, New Jersey, USA., Campbell B; Comparative Medicine, R&D, Pfizer Inc, Groton, Connecticut, USA.
Publikováno v:
Pharmaceutical statistics [Pharm Stat] 2024 Jun 11. Date of Electronic Publication: 2024 Jun 11.
Autor:
Palazzi X; Drug Safety Research and Development, Pfizer Inc, 445, Eastern Point Road, Groton CT, USA. Electronic address: xavier.palazzi@pfizer.com., Anger LT; Safety Assessment, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Boulineau T; Nonclinical Drug Safety, Boehringer Ingelheim, 900 Ridgebury Road, Ridgefield, CT, 06877, USA., Grevot A; Preclinical Safety, Novartis AG, Fabrikstrasse, Basel, Switzerland., Guffroy M; Preclinical Safety, AbbVie, 1 North Waukegan Road, R46G/AP13A-3, North Chicago, IL, 60064, USA., Henson K; Preclinical Safety, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936, USA., Hoepp N; Nonclinical Drug Safety, Merck and Co., Inc., Rahway, NJ, USA., Jacobsen M; Clinical Pharmacology and Safety Sciences, AstraZeneca, Biomedical Campus, 1 Francis Crick Ave, Cambridge, UK., Kale VP; Nonclinical Safety, Bristol Myers Squibb, 1 Squibb Dr, New Brunswick, NJ, 08901, USA., Kreeger J; Non-Clinical Safety, GSK, 1250 S. Collegeville Rd, Collegeville, PA, USA., Lane JH; Translational Safety & Bioanalytical Sciences, Amgen, Inc., 1 Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Li D; Global Biometrics & Data Management, Pfizer Inc, 445, Eastern Point Road, Groton CT, USA., Muster W; Pharmaceutical Sciences, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland., Paisley B; iBAR ADMET, Eli Lilly and Company, 893 Delaware St, Indianapolis, IN, USA., Ramaiah L; Preclinical Sciences and Translational Safety, Johnson & Johnson, 1400 McKean Road, PO Box 776, Spring House, PA, 19477, USA., Robertson N; Non-Clinical Safety, GSK, Gunnels Wood Road, Stevenage, SG1 2NY, UK., Shultz V; Nonclinical Development, Organon, 4000 Chemical Rd, Suite 500, Plymouth Meeting, PA, 19462, USA., Steger Hartmann T; Investigational Toxicology, BAYER AG, Pharmaceuticals, Muellerstrasse 178, 13342, Berlin, Germany., Westhouse R; Toxicology and Pathology, Agios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, USA.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2024 Jun; Vol. 150, pp. 105632. Date of Electronic Publication: 2024 Apr 27.
Autor:
Golden E; Center for Alternatives to Animal Testing (CAAT), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Allen D; Inotiv, Inc., Morrisville, NC, USA., Amberg A; Sanofi, Preclinical Safety, Frankfurt, Germany., Anger LT; Genentech Inc., South San Francisco, CA, USA., Baker E; Physicians Committee for Responsible Medicine, Washington, DC, USA, Baran SW; VeriSim Life, San Francisco, CA, USA., Bringezu F; Merck Healthcare KGaA, Chemical & Preclinical Safety, Darmstadt, Germany., Clark M; Charles River Laboratories, now KALOS Technologies, Philadelphia, PA, USA., Duchateau-Nguyen G; Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Escher SE; Fraunhofer ITEM, Hannover, Germany., Giri V; BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen am Rhein, Germany., Grevot A; Novartis Institute for Biomedical Research, Novartis AG, Basel, Switzerland., Hartung T; Center for Alternatives to Animal Testing (CAAT), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; CAAT-Europe, University of Konstanz, Konstanz, Germany., Li D; Pfizer, Global Biometrics and Data Management, Groton, CT, USA., Lotfi L; Charles River Laboratories, Boston, MA, USA, Muster W; Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Snyder K; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA., Wange R; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA., Steger-Hartmann T; Bayer AG, Pharmaceuticals, Investigational Toxicology, Berlin, Germany.
Publikováno v:
ALTEX [ALTEX] 2024; Vol. 41 (2), pp. 282-301. Date of Electronic Publication: 2023 Dec 01.
Autor:
Grove JI; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK.; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK., Stephens C; Servicios de Aparato Digestivo Y Farmacologia Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de La Victoria, Universidad de Málaga, Malaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain., Lucena MI; Servicios de Aparato Digestivo Y Farmacologia Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de La Victoria, Universidad de Málaga, Malaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain., Andrade RJ; Servicios de Aparato Digestivo Y Farmacologia Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de La Victoria, Universidad de Málaga, Malaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain., Weber S; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Gerbes A; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Bjornsson ES; Department of Gastroenterology, Landspitali University Hospital Reykjavik, University of Iceland, Reykjavík, Iceland.; Faculty of Medicine, University of Iceland, Reykjavík, Iceland., Stirnimann G; University Clinic for Visceral Surgery and Medicine, University Hospital Inselspital and University of Bern, Bern, Switzerland., Daly AK; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK., Hackl M; TAmiRNA GmbH, Vienna, Austria., Khamina-Kotisch K; TAmiRNA GmbH, Vienna, Austria., Marin JJG; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Monte MJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Paciga SA; Worldwide Research Development and Medical, Pfizer, NY, USA., Lingaya M; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK.; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK., Forootan SS; Centre for Drug Safety Science, University of Liverpool, Liverpool, UK., Goldring CEP; Centre for Drug Safety Science, University of Liverpool, Liverpool, UK., Poetz O; SIGNATOPE GmbH, 72770, Reutlingen, Germany., Lombaard R; ABX-CRO Advanced Pharmaceutical Services, Forschungsgesellschaft mbH, Cape Town, 7441, South Africa., Stege A; Charité-Universitätsmedizin Berlin, Central Biobank Charité (ZeBanC), Berlin, Germany., Bjorrnsson HK; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Robles-Diaz M; Servicios de Aparato Digestivo Y Farmacologia Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de La Victoria, Universidad de Málaga, Malaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain., Li D; Worldwide Research Development and Medical, Pfizer, NY, USA., Tran TDB; Worldwide Research Development and Medical, Pfizer, NY, USA., Ramaiah SK; Worldwide Research Development and Medical, Pfizer, NY, USA., Samodelov SL; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006, Zurich, Switzerland., Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006, Zurich, Switzerland.; Mechanistic Safety, CMO & Patient Safety, Global Drug Development, Novartis Pharma, 4056, Basel, Switzerland., Aithal GP; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK. guru.aithal@nottingham.ac.uk.; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK. guru.aithal@nottingham.ac.uk.
Publikováno v:
Diagnostic and prognostic research [Diagn Progn Res] 2023 Sep 12; Vol. 7 (1), pp. 18. Date of Electronic Publication: 2023 Sep 12.
Autor:
Rossman EI; GSK, Nonclinical Safety, Safety Pharmacology, Collegeville, PA, USA. Electronic address: eric.i.rossman@gsk.com., Wisialowski TA; Pfizer Worldwide Research Development and Medical, Safety Pharmacology, Groton, CT, USA., Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA., Valentin JP; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium., Rolf MG; AstraZeneca, Clinical Pharmacology & Safety Sciences, R&D, Gothenburg, Sweden., Roche BM; Charles River Laboratories, Global Safety Pharmacology, Ashland, OH, USA., Riley S; Pfizer Worldwide Research Development and Medical, Clinical Pharmacology, Groton, CT, USA., Pugsley MK; Cytokinetics, Toxicology, South San Francisco, CA, USA., Nichols J; Labcorp Early Development Laboratories Inc., Madison, WI, USA., Li D; Pfizer Global Product Development, Global Biometrics & Data Management, Groton, CT, USA., Leishman DJ; Eli Lilly and Company, Indianapolis, IN, USA., Kleiman RB; Clario, Philadelphia, PA, USA., Greiter-Wilke A; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Gintant GA; NuPharma Consulting, LLC, USA., Engwall MJ; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA., Delaunois A; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium., Authier S; Charles River Laboratories, Laval, QC, Canada.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2023 Sep-Oct; Vol. 123, pp. 107270. Date of Electronic Publication: 2023 May 08.
Autor:
Dertinger SD; Litron Laboratories, Rochester, New York, USA., Li D; Pfizer, Groton, Connecticut, USA., Beevers C; Corteva Agriscience, Oxford, UK., Douglas GR; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada., Heflich RH; U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas, USA., Lovell DP; St. George's Medical School, University of London, London, UK., Roberts DJ; Charles River Labs, Genetic & In Vitro Toxicology, Skokie, Illinois, USA., Smith R; Labcorp Drug Development, Harrogate, UK., Uno Y; LSI Medience, Co., Tokyo, Japan., Williams A; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada., Witt KL; Division of Translational Toxicology, National Institute of Environmental Health Sciences/National Institutes of Health, Research Triangle Park, North Carolina, USA., Zeller A; F. Hoffmann-La Roche, Ltd., Pharmaceutical Sciences, pRED Innovation Center Basel, Basel, Switzerland., Zhou C; Shanghai Innostar Bio-tech, Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, China.
Publikováno v:
Environmental and molecular mutagenesis [Environ Mol Mutagen] 2023 Apr 25. Date of Electronic Publication: 2023 Apr 25.
Autor:
Li X; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA., Li D; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA., Biddle KE; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA., Portugal SS; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA., Li MR; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA., Santos R; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA., Burkhardt JE; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA., Khan NK; Drug Safety Research & Development and Comparative Medicine. Pfizer, Inc., Groton, Connecticut, USA.
Publikováno v:
Veterinary clinical pathology [Vet Clin Pathol] 2022 Sep; Vol. 51 (3), pp. 356-375. Date of Electronic Publication: 2022 May 24.